Song, J. R., Jeon, J., Baek, S. C., Sharma, A., Sagong, M., Lee, C. S., Woo, S. J., Regillo, C., Khanani, A. M., Eichenbaum, D., Kuppermann, B. D., Loewenstein, A., Bandello, F., Nicholson, L., Vazquez-Alfageme, C., Boyer, D., Kumar, N., Parachuri, N., Banker, A., Rezaei, K. A., Kaiser, P. K., Holz, F. G., Sivaprasad, S., Wakabayashi, T., Querques, G., Özdek, Å., Laurent, K., Bilgic, A., Lanzetta, P., Baumal, C. R., Holekemp, N., Sakamoto, T., Tufail, A., Yannuzzi, N., Corradetti, G., Sheth, J., Mishra, C., Chakraborty, D., Rachitskaya, A., Peto, T., Wintergerst, M. W. M., Sarao, V., Parolini, B., Falavarjani, K. G., Nguyen, Q. D., Do, D. V., Keane, P. A., Hassan, T., Sridhar, J., Grewal, D. S., March, F., Spitzer, M., Zinkernagel, M. S., Ueda-Consolvo, T., Ishida, M., Nakamura, T., Yanagisawa, S., Tsuboi, K., Hayashi, A., Kim, J. (2026). Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study. Scientific Reports. https://doi.org/10.1038/s41598-026-52212-4